Edition:
United Kingdom

Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

10.35USD
4:04pm BST
Change (% chg)

$0.45 (+4.55%)
Prev Close
$9.90
Open
$9.85
Day's High
$10.45
Day's Low
$9.85
Volume
24,245
Avg. Vol
88,819
52-wk High
$21.35
52-wk Low
$8.62

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Mott

52 2016 Independent Chairman of the Board

Robert Bazemore

50 2015 President, Chief Executive Officer, Director

Suzanne Fleming

57 2018 Principal Financial Officer, Senior Vice President - Finance, Principal Accounting Officer, Treasurer

Matthew Ros

51 2016 Chief Operating Officer

Jason Fredette

2018 Vice President of Investor Relations